Most Clicked StoriesMore >


U.S. FDA sued by Ranbaxy for revoking approvals

DIA Global SmartBrief | Nov 20, 2014

Ranbaxy filed suit against the U.S. FDA for rescinding its approval of the India-based company's launch of generics of two drugs, including AstraZeneca's Nexium. The FDA claimed Ranbaxy's plants did not meet the agency's manufacturing quality standards at the time. In its suit, Ranbaxy called the move "arbitrary, capricious, and otherwise contrary to law." Reuters (11/18)


Study: Pharma competition rules influence drug prices, development

DIA Global SmartBrief | Nov 18, 2014

Doctors Without Borders to begin trials of experimental Ebola therapies

DIA Global SmartBrief | Nov 18, 2014

Coalition of funders seeks to advance treatments for neurodegenerative diseases

DIA Global SmartBrief | Nov 20, 2014

Study IDs protein that protects against age-related macular degeneration

DIA Global SmartBrief | Nov 18, 2014

Merck, Pfizer join forces to develop immuno-oncology drug

DIA Global SmartBrief | Nov 20, 2014

Study: Immunotherapy treatment of advanced melanoma outperforms standard chemo

DIA Global SmartBrief | Nov 18, 2014

Actavis to purchase Allergan in $66B deal

DIA Global SmartBrief | Nov 18, 2014

Sun Pharma recalls anti-depression drug in U.S. for failing dissolution specification

DIA Global SmartBrief | Nov 20, 2014

Topical delivery of medication presents new opportunities

DIA Global SmartBrief | Nov 20, 2014


Find DIA Global SmartBrief Issues by Date:



DIA News More >


Discover, innovate and advance with DIA

DIA Global SmartBrief | Nov 25, 2014

DIA: The global connector in the life sciences product development life cycle

DIA Global SmartBrief | Nov 18, 2014

Personal insights, professionally delivered

DIA Global SmartBrief | Nov 13, 2014

DIA education and networking opportunities

DIA Global SmartBrief | Nov 11, 2014

DIA educational and networking opportunities

DIA Global SmartBrief | Nov 06, 2014




Sign up for DIA Global SmartBrief



Designed specifically for the global drug development professional, the DIA Global SmartBrief is a FREE, twice weekly e-mail newsletter. By providing the latest need-to-know industry news and information, the DIA Global SmartBrief saves you time and keeps you smart. Learn more